提醒:代购产品,无质量问题不接受退换货,下单前请仔细核对信息。下单后请及时联系客服 核对商品价格,订单生效后再付款。
Diapharma/M30 CytoDeath™ CK18 Kit/P10900/Kit/96 tests
价格:

自营商城

解放采购

正品保障

及时交付

厂家直采

一站服务

货号:
品牌:
会员服务:
尊享会员价
贵宾专线
运费优惠
闪电退款
福利优惠
上门换新
友情提示
以上价格仅为参考,请联系客服询价。
免费咨询热线
4000-520-616
产品说明
Description:TheM30CytoDeath™ELISAisanovelresearchkit developedforcellcultureapplications.TheM30CytoDeath™assayhasadynamicrangeandsensitivitysuitableforinvitrowork.M30CytoDeath™ELISAisapowerfuldrugscreeningtool.Itisusefulforinvitrocharacterizationofapoptosis-inducingdrugs,includingestablishmentoftimecoursekineticsanddoseresponserelationships.TheeffectsoflargenumbersofsiRNAsonapoptosiscanbetestedinthe96wellformat.Theassayoffersauniquepossibilitytoquantifyapoptosisofepitheliallyderivedcellsinmulticellularspheroidsandorganculturesystems.TheM30CytoDeath™ELISAisbasedontheM30antibody(detectingtheAsp396caspase-cleavagesiteonCK18)andantibodyM6.ThiscombinationisdifferentfromthatusedintheM30-Apoptosense®ELISA.TheM30CytoDeath™ELISAisnotsuitableforserum/plasma.CK18KitAdvantages:SpecificallymeasureepithelialapoptosisincellcultureapplicationsTheassayhasadynamicrangeandsensitivitysuitableforinvitroworkSpecificquantificationmeasurementtoolforapoptosisinCK18positivecellsMeasuresastable,accumulatedproductallowingformeasurementat1latertimepointSandwichELISAina96wellplateinaconvenientready-to-useformatEasytoperform,onlyaminimumofpipettingstepsrequiredCK18ispresentinsimple epithelialcellsonly,thusincreasingspecificityofmeasurementinepithelial-basedmodelsPowerfultoolforinvitrocharacterizationofapoptosis-inducingdrugs.Mesauresformationofacapase-cleavageproductintheinteriorofspheroidsUseoftissueslicesfromexvivotumorstomeasureapoptosisofcandidatedrugsKeyadvantageinco‐culturesystemstodeterminedrugeffectonepithelialtissueCK18KitComposition:Reagents,Packaging,Storage,andStABIlityM6CoatedMicrostrips:Onemicroplate,12stripswith8wellseach,96dry wellsintotal.ThewellsarecoatedwithmousemonoclonalK18antibodyM6. Themicroplateissealedinanaluminiumbag,whichcontainsadesiccatingdevice. Ifnotallthestripsareused,resealthebagandkeepthedesiccatingdevice inside.Readyforuse!M30CytoDeathHRPConjugate:Concentrate(24×conc.).Onevialcontaining 0.4mLofmousemonoclonalM30antibody(anti-K18Asp396neo-epitope)conjugated withhorserADIshperoxidase(HRP)inaphosphatebufferwithprotein stabilizers.Preservativeadded.ShouldbedilutedwithM30CytoDeathConjugate DilutionBuffer(seeInstructionsforUsesection“ComponentPreparation”onpage9).Note!Do notexposetolight!M30CytoDeathConjugateDilutionBuffer:Onevialcontaining11mLofphosphate bufferwithproteinstabilizersfordilutionoftheM30CytoDeathHRPConjugate. Preservativeadded.Greencolored.M30CytoDeathStandards:StandardZerocontaining0.5mLofphosphate bufferwithfetalcalfserum(FCS).StandardsLow,MediumandHigh,0.5mL each,containingstandardmaterialinaphosphatebufferwithFCS.Thevaluesof theStandardsare0U/L(Zero),250U/L(Low),1000U/L(Medium)and3000U/L (High).Preservativeadded.Yellowcolored.Readyforuse!StandardZerocan beusedfordilutionsofsamples>3000U/L.WashTablet:Onetabletfor500mLofpreparedwashsolution.Dissolvethe WashTabletin500mLoffreshdeionisedwater.TMBSubstrate:Onebottlecontaining22mLofTMB(3,3’,5,5’-Tetramethylbenzidine) Substrate.Note!Donotexposetolight!Readyforuse!StopSolution:Onevialcontaining7mLof1.0Msulphuricacid.Readyforuse!SealingTape:One(1)sheet. MeasurementPrinciple:TheM30CytoDeath™ELISAisasolid-phasesandwichenzymeimmunoassay. StandardsandsamplesreactwithasolidphasecaptureantibodyM6directed againstK18andtheHRP(horseradishperoxidase)conjugatedM30antibody directedagainsttheK18Asp396neo-epitope.Unboundconjugateisremoved byawashingstep.TMBSubstrateisadded.Thecolordevelopmentisstoppedandtheabsorbanceisread.Theresultingcolorisdirectlyproportionaltothe concentrationoftheanalyte. Byplottingastandardcurvefromknownconcentrationsversusmeasuredabsorbance, theamountofantigeninthesamplecanbecalculated.Theconcentration oftheantigenisexpressedasunitsperliter(U/L).Background:Inastudy presentedattheSOTMeetingin2014,toxicitytestingoncryopreserveddifferentiatedHepaRG™cellswasperformedusingCK18kits.HepaRG™cellsexhibitmanycharacteristicsofprimaryhumanhepatocytes,includingmorphologyandexpressionofkeymetabolicenzymes,nuclearreceptors,anddrugtransporters.UnlikeHepG2cells,HepaRG™cellshavehighP450activityandcompleteexpressionofallnuclearreceptors.HepaRG™wasexposedtodifferentcompounds,includingparacetamol,chloropromazine,rotenone,rosiglitazoneandomeprazole.ToxicityandapoptosiswereassayedfromcollectedcellculturesupernatantsmeasuringM65andM30levels.M65resultswereconsistentwithcellviability,whereas,M30resultsindicatedthatapoptosiswasinducedatlowerdrugconcentrationswhilenecrosiswasmoreprominentathigherones(seefigurebelow).HumanHepRG™hepatocytestreatedwithdifferentcompounds.Toxicityandapoptosiswereassessedfromcollectedsupernatantsmeasuringfull-lengthK18(M65)andcaspase-cleavedK18(ccK18,M30)usingM65EpiDeath®andM30CytoDeath™ELISA.M65andM30kitsrobustlydetectcelltoxicityandapoptosisinHepaRGcells invitroexperiments. Aadditionalkeyfeatureisthatthe CK18kits measurean accumulated caspase-derivedproduct,sothereisnorisktomisstimeofapoptosisandtransientcaspaseactivation(Seefigurebelow). 

Diapharma使命宣言




位于俄亥俄州西切斯特的Difarma Group,Inc.在诊断和研究领域销售止血、血栓形成、血小板功能测试、仪器和凋亡产品,并提供强大的技术能力和经验,以确保满足或超过客户的期望。




地黄止血显色凝块酶联免疫吸附试验试剂盒






历史




1997年1月1日,由俄亥俄州富兰克林市的Pharmacia Hepar,Inc.成立,最初是Chromogenix基质和分析的独家美国和加拿大经销商。




四分之一个多世纪前,Chromogenix开发了第一个显色底物技术,其前身是Kabi Diagnostica。卡比后来与法玛西亚合并。希帕玛目前的一些员工在法玛西亚肝素制造厂的显色部门工作。




1998年,夏帕玛搬到了俄亥俄州的西切斯特,至今仍在那里。多年来,迪法玛扩大了其产品线,包括各种止血、细胞死亡、血小板功能、生态毒理学、化验、试剂、抗体和高级制造商的仪器。




2017年,夏帕玛庆祝了20年的成功


客服在线
service-logo
已有 人查看该问题
tel
全国免费服务热线
4000-520-616
微信公众号
关注我们
手机扫码,关注动态